Enhanced Dynamic Risk Stratification in Hematology

Created using ChatSlide

This research delves into SMM progression to MM, focusing on overcoming the limitations of static biomarkers through a large cohort study employing the PANGEA-SMM risk model and four evolving biomarkers. Findings reveal certain biomarkers rapidly accelerate progression and establish PANGEA-SMM's superior accuracy and validation across cohorts. The study underscores the model's utility for dynamic monitoring and clinical decision-making, comparing favorably against 20/2/20 and IMWG models....